Levetiracetam Solution
Product Images NDC 68999-548

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam Solution (NDC 68999-548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Governmental & Specialty Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Levetiracetam Os 5ml Unit Dose Label)

Label for LEVETIRACETAM oral solution USP delivering 5 mL with a strength of 500 mg/5 mL. The round label includes the NDC number 68999-548-45 and states Rx only for institutional use. Manufactured for Chartwell Governmental & Specialty RX, LLC, Congers, NY, it features a barcode and prompts to see the insert or MedGuide.*

FDA Label Image

"image Description" (Levetiracetam Os Fig 1)

A bar graph comparing the percentage of a measured response across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The percentages are approximately 7.4% for placebo, 37.1% for 1000 mg/day, and 39.6% for 3000 mg/day, with asterisks indicating statistical significance for the Levetiracetam groups.*

FDA Label Image

"image Description" (Levetiracetam Os Fig 2)

Bar chart showing percentages of patients in three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). It visually compares patient response rates across the treatment doses and placebo.*

FDA Label Image

"image Description" (Levetiracetam Os Fig 3)

A bar chart comparing the percentage of patients between placebo and Levetiracetam 3000 mg/day groups. The y-axis shows percentage of patients from 0% to 45%. The placebo group (n=104) shows approximately 14.4%, while the Levetiracetam group (n=180) shows approximately 39.4%, marked with an asterisk for significance indication.*

FDA Label Image

"image Description" (Levetiracetam Os Fig 4)

A bar chart comparing percentages of patients between a placebo group (19.6%) and a levetiracetam group (44.6%). The x-axis labels the groups as Placebo (N=97) and Levetiracetam (N=101), while the y-axis shows the percentage of patients ranging from 0% to 45%.*

FDA Label Image

"image Description" (Levetiracetam Os Fig 5)

A vertical bar chart comparing the percentage of patients in two groups: Placebo (N=51) and Levetiracetam (N=58). The bars show approximately 19.6% for the Placebo group and 43.1% for the Levetiracetam group with an asterisk indicating statistical significance.*

FDA Label Image

"image Description" (Levetiracetam Os Fig 6)

A bar chart comparing the percentage of patients between two groups: placebo and Levetiracetam. The placebo group shows 45.2% of patients, while the Levetiracetam group shows 72.2%. The chart includes sample sizes (N=84 for placebo and N=79 for Levetiracetam).*

FDA Label Image

"image Description" (Levetiracetam Os For 1)

A formula detailing the calculation of the daily dose for the medication LEVETIRACETAM solution. It shows the total daily dose in mL/day as the product of daily dose in mg/kg/day and patient weight in kg, divided by the solution strength of 100 mg/mL.*

FDA Label Image

"image Description" (Levetiracetam Os For 2)

A formula panel showing a calculation for creatinine clearance (CLcr) based on age, weight, serum creatinine, with an adjustment factor for female patients, possibly related to dosage adjustment for LEVETIRACETAM solution.*

FDA Label Image

"image Description" (Levetiracetam Os For 3)

A mathematical formula illustrating the calculation for creatinine clearance (CLcr) normalized to body surface area (BSA). The formula shows CLcr in mL/min per 1.73 m² as the ratio of measured creatinine clearance (mL/min/1.73 m²) divided by the subject's BSA (m²), multiplied by 1.73.*

FDA Label Image

"image Description" (Levetiracetam Os Structure)

Chemical structure of levetiracetam, depicting the molecular arrangement of atoms characteristic of this active ingredient used in the oral solution form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.